» Articles » PMID: 34051704

A Common Genetic Variant in Fatty Acid Amide Hydrolase is Linked to Alterations in Fear Extinction Neural Circuitry in a Racially Diverse, Nonclinical Sample of Adults

Overview
Journal J Neurosci Res
Specialty Neurology
Date 2021 May 29
PMID 34051704
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Poor fear extinction learning and recall are linked to the development of fear-based disorders, like posttraumatic stress disorder, and are associated with aberrant activation of fear-related neural circuitry. This includes greater amygdala activation during extinction learning and lesser hippocampal and ventromedial prefrontal cortex (vmPFC) activation during recall. Emerging data indicate that genetic variation in fatty acid amide hydrolase (FAAH C385A; rs324420) is associated with increased peripheral endocannabinoid (eCB) levels and lesser threat-related amygdala reactivity. Preclinical studies link increased eCB signaling to better extinction learning and recall, thus FAAH C385A may protect against the development of trauma-related psychopathology by facilitating extinction learning. However, how this FAAH variant affects fear extinction neural circuitry remains unknown. In the present study, we used a novel, immersive-reality fear extinction paradigm paired with functional neuroimaging to assess FAAH C385A effects on fear-related neural circuitry and conditioned fear responding (US expectancy ratings, subjective units of distress, and skin conductance responding) in healthy adults from an urban area (Detroit, MI; N = 59; C/C = 35, A-carrier = 24). We found lesser amygdala activation in A-allele carriers, compared to C/C homozygotes, during early extinction recall. Likewise, we found lesser dorsal anterior cingulate cortex and greater hippocampus activation in early extinction learning in A-carriers compared to C/C homozygotes. We found no effects of FAAH C385A on vmPFC activation or behavioral fear indices. These data support and extend previous findings that FAAH genetic variation, associated with increased eCB signaling and subsequent enhanced fear extinction, may predict individual differences in successful fear learning.

Citing Articles

Alterations of the endocannabinoid system in adolescents with non-suicidal self-injury as a function of childhood maltreatment.

Ferger M, Sigrist C, Brodesser S, Kaess M, Koenig J Transl Psychiatry. 2024; 14(1):491.

PMID: 39695136 PMC: 11655887. DOI: 10.1038/s41398-024-03205-2.


Endocannabinoid dysregulation and PTSD in urban adolescents: Associations with anandamide concentrations and FAAH genotype.

Marusak H, Ely S, Zundel C, Gowatch L, Shampine M, Carpenter C Psychopharmacology (Berl). 2024; .

PMID: 39547971 DOI: 10.1007/s00213-024-06717-3.


The Role of Genetic Variations in the FAAH rs324420 Polymorphism and its Interaction with CRHR1 rs110402 and CNR1 rs2180619 in Anxiety and- Trauma Related Symptoms After Military Deployment.

Leen N, de Weijer A, Boks M, Baas J, Vermetten E, Geuze E Chronic Stress (Thousand Oaks). 2024; 8:24705470241285828.

PMID: 39484094 PMC: 11526235. DOI: 10.1177/24705470241285828.


Genetic variation in endocannabinoid signaling: Anxiety, depression, and threat- and reward-related brain functioning during the transition into adolescence.

Desai S, Zundel C, Evanski J, Gowatch L, Bhogal A, Ely S Behav Brain Res. 2024; 463:114925.

PMID: 38423255 PMC: 10977105. DOI: 10.1016/j.bbr.2024.114925.


rs324420 Polymorphism: Biological Pathways, Impact on Elite Athletic Performance and Insights for Sport Medicine.

Silva H, Tavares V, Neto B, Cerqueira F, Medeiros R, Silva M Genes (Basel). 2023; 14(10).

PMID: 37895295 PMC: 10606937. DOI: 10.3390/genes14101946.


References
1.
Kessler R, Berglund P, Demler O, Jin R, Merikangas K, Walters E . Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6):593-602. DOI: 10.1001/archpsyc.62.6.593. View

2.
Friston K, Fletcher P, Josephs O, Holmes A, Rugg M, Turner R . Event-related fMRI: characterizing differential responses. Neuroimage. 1998; 7(1):30-40. DOI: 10.1006/nimg.1997.0306. View

3.
Katona I, Rancz E, Acsady L, Ledent C, Mackie K, Hajos N . Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci. 2001; 21(23):9506-18. PMC: 6763903. View

4.
Gartner A, Dorfel D, Diers K, Witt S, Strobel A, Brocke B . Impact of FAAH genetic variation on fronto-amygdala function during emotional processing. Eur Arch Psychiatry Clin Neurosci. 2018; 269(2):209-221. DOI: 10.1007/s00406-018-0944-9. View

5.
Marsicano G, Lutz B . Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest. 2006; 29(3 Suppl):27-46. View